Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning
- PMID: 33121625
- PMCID: PMC7414299
- DOI: 10.1016/j.cll.2020.08.014
Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning
Abstract
The entire spectrum of diagnostic testing, from reagent supply to test performance, has been a major focus during the coronavirus disease 2019 (COVID-19) pandemic. The hope for serologic testing is that it will provide both epidemiologic information about seroprevalence as well as individual information about previous infection. This information is particularly helpful for high-risk individuals who may be outside of the viral shedding window, such as children with suspected multisystem inflammatory syndrome. It is not yet understood whether serologic testing can be interpreted in terms of protective immunity. These concerns must be addressed using highly sensitive and specific tests.
Keywords: COVID-19; COVID-19 serology; SARS-CoV-2.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Nicole Pecora has received research support from Luminex.
Figures




References
-
- Zainol Rashid Z., Othman S.N., Abdul Samat M.N., et al. Diagnostic performance of COVID-19 serology assays. Malays J Pathol. 2020;42(1):13–21. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous